Skip to main content

Advertisement

Log in

Bing–Neel syndrome: an illustrative case and a comprehensive review of the published literature

  • Topic Review
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Waldenstrom’s macroglobulinemia (WM) is a chronic lymphoproliferative disorder within the spectrum of lymphoplasmacytic lymphoma characterized by proliferation of plasma cells, small lymphocytes, and plasmacytoid lymphocytes. Central nervous system involvement is very rare (Bing–Neel [BN] syndrome). We present the case of a 62-year-old woman previously diagnosed with WM who presented with Bing–Neel syndrome and review the published literature which consists of only case reports. We performed a Medline search using the terms “Waldenstrom’s macroglobulinemia and central nervous system” and “Bing–Neel” collecting data on presentation, evaluation, treatment, and outcome and summarizing these findings in the largest pooled series to date. Central nervous system manifestations are localization related. Serum laboratory testing reflects systemic disease. Cerebrospinal fluid analysis may show lymphocytic pleocytosis, elevated protein, and IgM kappa or lambda light chain restriction; cytology results are variable. Imaging is frequently abnormal. Biopsy confirms the diagnosis. Treatment data are limited, but responses are seen with radiation and/or chemotherapy. BN syndrome is a very rare complication of WM that should be considered in patients with neurologic symptoms and a history of WM. Treatment should be initiated as responses do occur that may improve quality of life and extend it when limited or no active systemic disease is present.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Swerdlow SH, International Agency for Research on Cancer, World Health Organization (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on Cancer, Lyon, France

    Google Scholar 

  2. Waldenstrom J (1944) Incipient myelomatosis or “essential” hyperglobulinemia with fibrogenopenia: a new syndrome? Acta Med Scand 117:216–247

    Google Scholar 

  3. Bing J, Neel A (1936) Two cases of hyperglobulinemia with affection of the central nervous system on a toxi-infection bases. Acta Med Scand 88:492–506

    Google Scholar 

  4. Vula O, Merhaien P (1972) Cerebral reticuloplasmacytosis with hyperglobulinemia. Its relation to the Bing-Neel syndrome. Eur Neurol 7:155–168

    Article  CAS  PubMed  Google Scholar 

  5. Imai F, Fujisawa K, Kiya N, Ninomiya T, Ogura Y, Mizoguchi Y, Sano H, Kanno T (1995) Intracerebral infiltration by monoclonal plasmacytoid cells in Waldenstrom’s macroglobulinemia—case report. Neurol Med Chir (Tokyo) 35:575–579

    Article  CAS  Google Scholar 

  6. Logothetis J, Silverstein P, Coe J (1960) Neurologic aspects of Waldenstrom’s macroglobulinemia; report of a case. Arch Neurol 3:564–573

    CAS  PubMed  Google Scholar 

  7. Edgar R, Dutcher TF (1961) Histopathology of the Bing-Neel syndrome. Neurology 11:239–245

    CAS  PubMed  Google Scholar 

  8. Bhatti MT, Yuan C, Winter W, McSwain AS, Okun MS (2005) Bilateral sixth nerve paresis in the Bing-Neel syndrome. Neurology 64:576–577

    CAS  PubMed  Google Scholar 

  9. Torrey JJ, Katakkar SB (1984) Treatable meningeal involvement in Waldenstrom’s macroglobulinemia. Ann Intern Med 101:345–347

    CAS  PubMed  Google Scholar 

  10. Neau JP, Guilhot F, Dumas P, Besson I, Rivasseau-Jonveaux T, Gil R (1991) [Central neurologic forms of Waldenstrom’s disease Bing-Neel syndrome. 3 cases]. Rev Neurol (Paris) 147:56–60

    CAS  Google Scholar 

  11. Delgado J, Canales MA, Garcia B, Alvarez-Ferreira J, Garcia-Grande A, Hernandez-Navarro F (2002) Radiation therapy and combination of cladribine, cyclophosphamide, and prednisone as treatment of Bing-Neel syndrome: case report and review of the literature. Am J Hematol 69:127–131

    Article  CAS  PubMed  Google Scholar 

  12. Donix M, Beuthien-Baumann B, von Kummer R, Gahn G, Thomas F, Holthoff V (2007) Nonfluent aphasia in a patient with Waldenstrom’s macroglobulinemia. J Clin Neurosci 14:601–603

    Article  PubMed  Google Scholar 

  13. Fain O, Wechsler B, Vidailhet M, Raphael M, Schuller E, Godeau P (1992) [Involvement of central nervous system disclosing Waldenstrom’s disease: demonstration of intrathecal secretion of immunoglobulin M]. Rev Med Interne 13:58–60

    Article  CAS  PubMed  Google Scholar 

  14. Garderet L, Baudel JL, Cervera P, Azizi L, Maury E, Guidet B, Gorin NC, Offenstadt G (2006) ‘Indolent’ Waldenstrom’s macroglobulinemia and a cerebrospinal fluid protein level of 16 g/L. Eur J Haematol 77:80–82

    Article  PubMed  Google Scholar 

  15. Welch D, Whetsell WO Jr, Weil RJ (2002) Pathologic quiz case. A man with long-standing monoclonal gammopathy and new onset of confusion. Central nervous system involvement by Waldenstrom macroglobulinemia-Bing-Neel syndrome. Arch Pathol Lab Med 126:1243–1244

    PubMed  Google Scholar 

  16. Scheithauer BW, Rubinstein LJ, Herman MM (1984) Leukoencephalopathy in Waldenstrom’s macroglobulinemia. Immunohistochemical and electron microscopic observations. J Neuropathol Exp Neurol 43:408–425

    Article  CAS  PubMed  Google Scholar 

  17. Weiss AH, Smith E, Christoff N, Kochwa S (1965) Cerebrospinal fluid paraproteins in multiple myeloma. J Lab Clin Med 66:280–293

    CAS  PubMed  Google Scholar 

  18. Frantzen E, Hertz H, Matzke J, Videbaek A (1969) Protein studies on cerebrospinal fluid and neurological symptoms in myelomatosis. Acta Neurol Scand 45:1–17

    Article  CAS  PubMed  Google Scholar 

  19. Hansotia P, Gani K, Friedenberg W (1983) Cerebrospinal fluid monoclonal gammopathy in multiple myeloma and Waldenstrom’s macroglobulinemia. Neurology 33:1411–1415

    CAS  PubMed  Google Scholar 

  20. Dimopoulos MA, Kantarjian H, Weber D, O’Brien S, Estey E, Delasalle K, Rose E, Cabanillas F, Keating M, Alexanian R (1994) Primary therapy of Waldenstrom’s macroglobulinemia with 2-chlorodeoxyadenosine. J Clin Oncol 12:2694–2698

    CAS  PubMed  Google Scholar 

  21. Laurencet FM, Zulian GB, Guetty-Alberto M, Iten PA, Betticher DC, Alberto P (1999) Cladribine with cyclophosphamide and prednisone in the management of low-grade lymphoproliferative malignancies. Br J Cancer 79:1215–1219

    Article  CAS  PubMed  Google Scholar 

  22. Richards AI (1995) Response of meningeal Waldenstrom’s macroglobulinemia to 2-chlorodeoxyadenosine. J Clin Oncol 13:2476

    CAS  PubMed  Google Scholar 

  23. Dimopoulos MA, Anagnostopoulos A, Kyrtsonis MC, Zervas K, Tsatalas C, Kokkinis G, Repoussis P, Symeonidis A, Delimpasi S, Katodritou E, Vervessou E, Michali E, Pouli A, Gika D, Vassou A, Terpos E, Anagnostopoulos N, Economopoulos T, Pangalis G (2007) Primary treatment of Waldenstrom macroglobulinemia with dexamethasone, rituximab, and cyclophosphamide. J Clin Oncol 25:3344–3349

    Article  CAS  PubMed  Google Scholar 

  24. Treon SP, Emmanouilides C, Kimby E, Kelliher A, Preffer F, Branagan AR, Anderson KC, Frankel SR (2005) Extended rituximab therapy in Waldenstrom’s macroglobulinemia. Ann Oncol 16:132–138

    Article  CAS  PubMed  Google Scholar 

  25. Weide R, Heymanns J, Koppler H (1999) Induction of complete haematological remission after monotherapy with anti-CD20 monoclonal antibody (RITUXIMAB) in a patient with alkylating agent resistant Waldenstrom’s macroglobulinaemia. Leuk Lymphoma 36:203–206

    Article  CAS  PubMed  Google Scholar 

  26. Weide R, Heymanns J, Koppler H (2000) The polyneuropathy associated with Waldenstrom’s macroglobulinaemia can be treated effectively with chemotherapy and the anti-CD20 monoclonal antibody rituximab. Br J Haematol 109:838–841

    Article  CAS  PubMed  Google Scholar 

  27. Bing J, Fog M, Neel A (1937) Reports of a third case of hyperglobulinemia with affection of the central nervous system on a toxi-infectious basis, and some remarks on the differential diagnosis. Acta Med Scand 91:409–427

    Google Scholar 

  28. Tommasi M, Revol L, Schott B, Lesbros F (1966) [Waldenstrom’s macroglobulinemia. Lesions of the central nervous system]. Ann Anat Pathol (Paris) 11:309–313

    CAS  Google Scholar 

  29. Pennacchio L, Orlandini M (1969) [Immunoglobulin diseases. (Basis of modern immunology. Clinical contribution. Bing-Neel syndrome)]. Policlinico Prat 76:401–422

    CAS  PubMed  Google Scholar 

  30. Quilichini R, Benderitter T, Lafeuillade A, Chaffanjon P, Aubert L (1989) [Waldenstrom’s macroglobulinemia with cerebral lymphoproliferative involvement of tumor appearance (Bing and Neel syndrome). An anatomo-clinical case]. Ann Med Interne (Paris) 140:25–29

    CAS  Google Scholar 

  31. Jammes T, Mann C, Delhom E, Bertrand P, Berthelemy C, Oweini K, Jonquet O (1990) [Bing-Neel syndrome revealed by normal pressure hydrocephalus. Unusual clinical/course of Waldenstrom disease]. Presse Med 19:1992

    CAS  PubMed  Google Scholar 

  32. Shimizu K, Fujisawa K, Yamamoto H, Mizoguchi Y, Hara K (1993) Importance of central nervous system involvement by neoplastic cells in a patient with Waldenstrom’s macroglobulinemia developing neurologic abnormalities. Acta Haematol 90:206–208

    Article  CAS  PubMed  Google Scholar 

  33. Civit T, Coulbois S, Baylac F, Taillandier L, Auque J (1997) [Waldenstrom’s macroglobulinemia and cerebral lymphoplasmocytic proliferation: Bing and Neel syndrome. Apropos of a new case]. Neurochirurgie 43:245–249

    CAS  PubMed  Google Scholar 

  34. Arias M, Pereiro Zabala I, Requena Caballero I, Sesar Ignacio A, Arias Rivas S, Villamayor Blanco B (2004) [Rapidly progressing dementia as the presenting symptom of Waldenstrom’s macroglobulinemia: findings from magnetic resonance imaging of the brain in Bing Neel syndrome]. Rev Neurol 38:640–642

    CAS  PubMed  Google Scholar 

  35. Kim HD, Shin KC, Cho HS, Kim MK, Lee KH, Hyun MS (2007) Therapeutic experience of Bing-Neel syndrome associated with Waldenstrom’s macroglobulinemia. J Korean Med Sci 22:1079–1081

    Article  CAS  PubMed  Google Scholar 

  36. Drappatz J, Akar S, Fisher DC, Samuels MA, Kesari S (2008) Imaging of Bing-Neel syndrome. Neurology 70:1364

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement

We thank Dr. Jaun J. Cayaffa for translating the foreign articles.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeffrey J. Raizer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Malkani, R.G., Tallman, M., Gottardi-Littell, N. et al. Bing–Neel syndrome: an illustrative case and a comprehensive review of the published literature. J Neurooncol 96, 301–312 (2010). https://doi.org/10.1007/s11060-009-9968-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-009-9968-3

Keywords

Navigation